Provided for are three novel isoenzyme variants of the human Hyaluronan Synthase gene, HAS1Va, HAS1Vb, and HAS1Vc. Also provided is a method for assessing disease, or susceptibility to disease, in a patient; in which a cell or sample of a cell population is mixed with at least one compound which specifically...http://www.google.com.au/patents/US7504212?utm_source=gb-gplus-sharePatent US7504212 - Cancer monitoring and therapeutics
